Skip to content
Screener

Solventum SOLV Investing Cash Flow

Investing Cash Flow at other companies

Becton, Dickinson and Company logo
Becton, Dickinson and CompanyBDX
-$241M+28.3%
3M logo
3MMMM
-$483M-790%
Sanara MedTech Inc. logo
Sanara MedTech Inc.SMTI
-$43.77K+99.2%
Cardinal Health logo
Cardinal HealthCAH
-$181M+93.8%
UnitedHealth Group logo
UnitedHealth GroupUNH
-$2.45B-3,207%
DENTSPLY SIRONA logo
DENTSPLY SIRONAXRAY
-$39M-14.7%

Other financials

Income statement

See full
Revenue$2.2B+2.2%
Gross profit$1.3B+9.4%
Operating income$181.0M-15.4%
Net income$92.0M+2.2%
EPS (diluted)$0.53+3.9%

Balance sheet

See full
Cash & equivalents$403.0M-18.1%
Total debt$5.8B-25.9%
Total equity$4.8B+31.7%
Total assets$14.2B-5.5%

Cash flow

See full
Operating cash flow$227.0M+34.3%
CapEx$83.0M-24.5%
Free cash flow-$273.0M-241%

Valuation

See full
Market cap$15.15B+20.6%
Enterprise value$20.54B+3.3%
P/E10.6×-22.5×
P/S1.8×+0.3×

Profitability

See full
Gross margin54.7%+0.2pp
Operating margin25%+15.7pp
Net margin17.3%+12.7pp
FCF margin4.6%-13.9pp

Returns & leverage

See full
Return on equity34%+22.3pp
Debt / equity1.2×-0.9×
Current ratio-0.2×

Where this comes from

Reported directly by Solventum in its filing.

Tagged under the XBRL concept us-gaap:NetCashProvidedByUsedInInvestingActivities.

The source filing: Solventum’s 10-Q, filed August 5, 2026.

Filed
Aug 5, 2026, 5:27 PM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001964738-26-000047
(Millions)Six months ended June 30, 2026Six months ended June 30, 2025
Cash Flows from Investing Activities
Purchases of property, plant and equipment(167)(219)
Other — net3(5)
Net cash used in investing activities(164)(224)
Cash Flows from Financing Activities
Repayment of debt(200)
Proceeds from debt, net of issuance costs46
Net transfers from (to) 3M2(30)

Item 1. Financial Statements

FAQ

What is Solventum's investing cash flow?
Solventum (SOLV) reported investing cash flow of -$87M in Q2 2026.
How has Solventum's investing cash flow changed year-over-year?
Solventum's investing cash flow increased by 20.9% year-over-year, from -$110M to -$87M.
What is the long-term trend for Solventum's investing cash flow?
Over 2 years (2022 to 2024), Solventum's investing cash flow has grown at a 22.6% compound annual growth rate (CAGR), from -$253M to -$380M.
What does investing cash flow mean?
Total net cash provided by or used in investing activities — capex, acquisitions, investment purchases/sales, and other investing items.

Ask your AI about Solventum's investing cash flow.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude